Result of AGM

RNS Number : 0577G

GlaxoSmithKline PLC

05 May 2011

 



 GlaxoSmithKline plc - Result of AGM

GlaxoSmithKline plc (GSK) announces that at its Annual General Meeting today, all resolutions, including those electing and re-electing Board members, were passed by shareholders.

GlaxoSmithKline Annual General Meeting Poll Results

The following table shows the votes cast for each resolution:

Resolution		Total votes for*	%	Total votes against	%	Total votes cast	Votes withheld**
1	Adoption of Financial Statements	3,849,724,841	99.90	3,972,004	0.10	3,853,696,845	4,824,826
2	Approval of the Remuneration Report	3,506,794,850	92.88	268,917,463	7.12	3,775,712,313	82,829,542
3	Election of Simon Dingemans	3,848,384,170	99.88	4,592,054	0.12	3,852,976,224	5,550,786
4	Election of Ms Stacey Cartwright	3,841,823,906	99.71	11,062,363	0.29	3,852,886,269	5,643,742
5	Election of Ms Judy Lewent	3,843,559,263	99.75	9,499,395	0.25	3,853,058,658	5,471,278
6	Re-election of Sir Christopher Gent	3,736,569,130	96.97	116,649,598	3.03	3,853,218,728	5,314,008
7	Re-election of Andrew Witty	3,848,715,490	99.88	4,521,805	0.12	3,853,237,295	5,293,227
8	Re-election of Professor Sir Roy Anderson	3,849,621,453	99.91	3,645,550	0.09	3,853,267,003	5,262,933
9	Re-election of Dr Stephanie Burns	3,845,994,787	99.81	7,252,653	0.19	3,853,247,440	5,282,496
10	Re-election of Larry Culp	3,679,273,731	95.49	173,856,451	4.51	3,853,130,182	5,398,951
11	Re-election of Sir Crispin Davis	3,845,288,843	99.80	7,870,747	0.20	3,853,159,590	5,370,346
12	Re-election of Sir Deryck Maughan	3,618,533,477	93.91	234,597,016	6.09	3,853,130,493	5,409,443
13	Re-election of James Murdoch	3,749,042,808	97.30	103,982,301	2.70	3,853,025,109	5,504,826
14	Re-election of Dr Daniel Podolsky	3,849,525,259	99.91	3,602,607	0.09	3,853,127,866	5,402,070
15	Re-election of Dr Moncef Slaoui	3,848,000,866	99.87	5,004,470	0.13	3,853,005,336	5,225,725
16	Re-election of Tom de Swaan	3,767,791,974	97.78	85,429,903	2.22	3,853,221,877	5,318,058
17	Re-election of Sir Robert Wilson	3,849,258,200	99.90	4,000,688	0.10	3,853,258,888	5,270,983
18	Re-appointment of Auditors	3,772,864,832	99.32	25,647,503	0.68	3,798,512,335	60,025,660
19	Remuneration of Auditors	3,819,410,091	99.67	12,638,825	0.33	3,832,048,916	26,477,992
20	To authorise the company to make donations to political organisations and incur political expenditure	3,758,221,639	97.62	91,644,592	2.38	3,849,866,231	8,636,488
21	Authority to allot shares	3,781,033,581	98.16	70,843,798	1.84	3,851,877,379	6,624,572
22	Disapplication of pre-emption rights***	3,811,196,075	99.00	38,468,694	1.00	3,849,664,769	8,832,253
23	Authority for the Company to purchase its own shares***	3,786,160,872	98.25	67,324,020	1.75	3,853,484,892	5,049,760
24	Exemption from statement of senior statutory auditor's name	3,829,887,610	99.49	19,439,945	0.51	3,849,327,555	9,159,773
25	Reduced notice of a general meeting other than an AGM***	3,549,744,749	92.16	301,776,965	7.84	3,851,521,714	7,016,010

Notes:

*           Includes discretionary votes.

**         A vote withheld is not a vote in law and is not counted in the calculation of the proportion of votes "For" or "Against" a resolution.

***        Indicates Special Resolutions requiring a 75% majority.

The following table provides further relevant information:

	GlaxoSmithKline's Eleventh AGM (2011)	GlaxoSmithKline's Tenth AGM (2010)
Issued share capital (excluding Treasury Shares)	5,163,907,153	5,192,489,588
Total votes cast and votes withheld lodged as a % of GSK's issued share capital (excluding Treasury Shares)	74.72%	70.24%
Total shareholder population	155,990	164,450
Total number of proxies lodged	9,886	11,148
% of shareholders who lodged proxies	6.34%	6.78%
Number of shareholders, corporate representatives and proxies who attended the AGM	364	325

V A Whyte

Company Secretary

5 May 2011

These results will shortly be available on the Company's website www.gsk.com.

Enquiries:

GlaxoSmithKline Enquiries:
UK Media enquiries:	David Mawdsley	[phone]
	Claire Brough	[phone]
	Stephen Rea	[phone]
	Alexandra Harrison	[phone]
	David Daley	[phone]
US Media enquiries:	Nancy Pekarek	[phone]
	Mary Anne Rhyne	[phone]
	Kevin Colgan	[phone]
	Jennifer Armstrong	[phone]
European Analyst/Investor enquiries:	Sally Ferguson	[phone]
	Gary Davies	[phone]
	Ziba Shamsi	[phone]
US Analyst/ Investor enquiries:	Tom Curry	[phone]
	Jeff McLaughlin	[phone]

 

END

 

 

RAGDKPDQABKDQPK